Navigation Links
The risk of developing deep vein thrombosis during a flight is often overestimated
Date:7/23/2009

This release is available in German.

The risk of developing deep vein thrombosis during a long flight is often overestimated. According to the German Institute for Quality and Efficiency in Health Care (IQWiG), this condition is very unlikely in healthy travellers. When people wear a cast or splint after a sports accident, on the other hand, many are not aware that they have an increased risk of deep vein thrombosis in their leg and pelvic area. This is emphasised in information published today on IQWiG's website Informed Health Online.

Blood clots can travel to lungs, leading to pulmonary embolism

If you are unable to move your legs regularly, blood flow through your veins is slower than usual. As a result, blood may clump together, forming a blood clot which can lead to deep vein thrombosis. "This can become dangerous if the blood clot dislodges, travels to the lungs and blocks a blood vessel there," says the Institute's Director, Professor Peter Sawicki. "This complication, called a pulmonary embolism, can reduce the supply of oxygen to the body's cells, overstrain the heart and even cause heart failure."

Even in higher-risk groups the risk of air-travel-related thrombosis is still well below half a percent

During the travel season we often hear that long-haul flights increase the risk of deep vein thrombosis (sometimes called "economy class syndrome"). The Institute summarised the results of research on deep vein thrombosis and air travel, involving the experiences of millions of air travellers. They found that only about 2 to 5 out of every 10,000 people who took a flight longer than 6 to 8 hours developed deep vein thrombosis that caused symptoms (at the most 0.05%). Even people who had a higher risk for example, because they had large varicose veins or were very overweight were not highly likely to develop deep vein thrombosis: only 20 out of every 10,000 travellers were affected (0.2%). The Institute did not find any convincing evidence that people who flew for less than 4 to 6 hours had an increased risk of thrombosis.

"By the way," says Professor Sawicki, "if you want to lower your risk by wearing compression stockings, you should put them on at least 2 hours before the flight and keep them on throughout the entire journey. Research has shown that these stockings lower the risk of deep vein thrombosis somewhat when used in this way."

Wearing a cast or splint increases the risk of deep vein thrombosis

If people have to wear a cast or splint, for example after fracturing a bone or tearing a ligament, they can only move their leg a little bit, if at all. Many people do not know that this also increases the risk of developing a blood clot in a vein in their leg or pelvis. "To prevent serious complications, it is important to get back on your feet and move around again as soon as possible," stresses Professor Sawicki. "If that is not possible, for example because putting strain on the leg too soon could slow down recovery, there are effective medications that can be used." These so-called "anticoagulant" medications reduce the blood's ability to clot. Heparins are among the most established anticoagulant medications. They are injected subcutaneously (under the skin).


'/>"/>

Contact: Hilda Bastian
information@iqwig.de
49-221-356-850
Institute for Quality and Efficiency in Health Care
Source:Eurekalert

Related medicine news :

1. Clinical Research Safety and Ethical Standards in Developing World Up to U.S. Levels, Report Says
2. Brazil proves developing countries can use generic medicines to fight HIV/AIDS epidemic
3. Researchers identify individuals at risk for developing colon cancer
4. Rare sheep could be key to better diagnostic tests in developing world, says Stanford study
5. Living Alone Increases Odds of Developing Dementia
6. Research output in developing countries reveals 194 percent increase in five years
7. Leeds engineers developing bullet proof vests from cement
8. Prospect Therapeutics Inc.s GCS-100 Has Focused on Developing Treatment for Three Blood-Borne Cancers
9. Caucasians are at higher risk of developing Ewings sarcoma than other races
10. Thomson Reuters Partners with Research4Life to Bring Scientific Research Information Resources to Developing Countries Around the World
11. UCF researcher developing computer program to detect, measure brain tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2017)... ... ... The weather is heating up and the days are getting longer, providing the ... the summer months provide more than warmer temperatures that are perfect for BBQ’s and ... from direct exposure to the sun. When it comes to the security of homes ...
(Date:6/23/2017)... ... June 23, 2017 , ... The ... launch of Care Management Alerts and Dashboards, an innovative new service enabling healthcare ... , RIQI’s Care Management Alerts and Dashboards provide near real-time data about patients ...
(Date:6/23/2017)... CA (PRWEB) , ... June 23, 2017 , ... By ... earned its ninth consecutive four-star rating from premier online charity evaluator, Charity Navigator, validating ... the top 1% of all charities reviewed by Charity Navigator and earns ANRF a ...
(Date:6/23/2017)... ... ... show evidence that carotenoids and antioxidants derived either from the diet or from supplements ... often do ophthalmologists and optometrists in Sweden recommend the use of nutritional supplements, changes ... of AMD? A study published recently in Dove Medical Press journal, ...
(Date:6/23/2017)... , ... June 23, 2017 , ... ... surgeon practicing in Newburgh, New York, has recently begun offering three new minimally ... offering the best cutting-edge procedures and reducing downtime, Dr. Rubinstein is excited to ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... June 14, 2017  ivWatch LLC, a medical device ... intravenous (IV) therapy, is pleased to announce it was ... Nonsurgical Hospital Supplies and Equipment at the 2017 Medical ... the medtech industry. The award was presented by Medical ... Javits Center in New York ...
(Date:6/11/2017)...  Eli Lilly and Company (NYSE: LLY ) ... of galcanezumab, an investigational treatment for the prevention of ... key secondary endpoints for galcanezumab compared to placebo at ... EVOLVE-2 and REGAIN) will be presented today at the ... Boston . "The detailed ...
(Date:6/8/2017)...   Responding to Heath Ledger,s father,s recent ... singer Chris Cornell in May, the mental health ... free online psychiatric drug side effects search ... psychotropic drug risks. The father of the ... accidental overdose, has called for tighter rules on prescription drugs. ...
Breaking Medicine Technology: